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Abstract: 
Observational studies are the basis for much of our knowledge of 
veterinary pathology and are highly relevant to the daily practice of 
pathology. However, recommendations for conducting pathology-based 
observational studies are not readily available. In part 1 of this series, we 
offer advice on planning and conducting an observational study with 
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examples from the veterinary pathology literature. Investigators should 
recognize the importance of creativity, insight and innovation in devising 
studies that solve problems and fill important gaps in knowledge. Studies 
should focus on specific and testable hypotheses, questions or objectives. 
The methodology is developed to support these goals. We consider the 
merits and limitations of different types of analytic and descriptive studies, 
and of prospective versus retrospective enrollment. Investigators should 
define clear inclusion and exclusion criteria and select adequate numbers of 
study subjects, including careful selection of the most appropriate controls. 
Studies of causality must consider the temporal relationships between 
variables, and the advantages of measuring incident cases rather than 
prevalent cases. Investigators must consider unique aspects of studies 
based on archived laboratory case material, and take particular care to 
consider and mitigate the potential for selection bias and information bias. 
We close by discussing approaches to adding value and impact to 
observational studies. Part 2 of the series focuses on methodology and 
validation of methods. 
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Abstract 
Observational studies are the basis for much of our knowledge of veterinary pathology and are 
highly relevant to the daily practice of pathology. However, recommendations for conducting 
pathology-based observational studies are not readily available. In part 1 of this series, we 
offer advice on planning and conducting an observational study with examples from the 
veterinary pathology literature. Investigators should recognize the importance of creativity, 
insight and innovation in devising studies that solve problems and fill important gaps in 
knowledge. Studies should focus on specific and testable hypotheses, questions or objectives. 
The methodology is developed to support these goals. We consider the merits and limitations 
of different types of analytic and descriptive studies, and of prospective versus retrospective 
enrollment. Investigators should define clear inclusion and exclusion criteria and select 
adequate numbers of study subjects, including careful selection of the most appropriate 
controls. Studies of causality must consider the temporal relationships between variables, and 
the advantages of measuring incident cases rather than prevalent cases. Investigators must 
consider unique aspects of studies based on archived laboratory case material, and take 
particular care to consider and mitigate the potential for selection bias and information bias. 
We close by discussing approaches to adding value and impact to observational studies. Part 
2 of the series focuses on methodology and validation of methods. 
Keywords 
Reproducibility of Results, Research design, Epidemiology, Pathology, Descriptive studies, 
Observational studies, Study design, Case-control, Cohort, Hypothesis, Bias, Laboratory 
medicine 
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Observational studies are the foundation for most of the current knowledge that veterinary 
pathologists apply to their daily practice. The published literature contains considerable advice 
on designing and reporting observational studies, including the recent STROBE-Vet 
guidelines.31,39 However, these publications are oriented to epidemiology and often focus on 
studies of causation, whereas pathology-based studies more often investigate mechanisms or 
consequences of disease. Moreover, investigations based on archived laboratory case 
material have unique caveats and limitations that should be recognized in the early phases of 
study design.  
Here, editors and editorial board members of Veterinary Pathology and our colleagues present 
the sequential steps in devising and conducting observational studies in veterinary pathology. 
We also provide examples from published articles for clarity. This article is not intended as a 
list of requirements to publish in Veterinary Pathology because application of these principles 
will depend on the study context. Instead, the article describes principles intended to stimulate 
thinking on effective study design.  
This article—the first of a 2-part series—focuses on design and development of observational 
studies. We discuss devising the study, developing the rationale, and forming a specific 
hypothesis, question or objective. Next, we consider the details of study design: choosing 
between descriptive and analytic studies, types of analytic studies, prospective vs 
retrospective enrollment, study design considerations that pertain to causal inferences, 
selection and numbers of subjects for the study, and issues of bias, confounding and chance 
associations. Finally, we consider the need for careful critique of the study design, and 
approaches to adding value and rigor. The second article of the series8 addresses 
methodology and validation of methods. 
We should clarify a few terms. Study subjects are the individuals being studied, such as the 
cases and controls. Studies of causal association measure an exposure and an outcome. The 
exposure (independent variable) is presumed to precede the outcome (dependent variable). 
Depending on the study design, the disease could either be the exposure or the outcome. For 
example, a virus infection could be the exposure and pneumonia is the outcome, or 
pneumonia could be the exposure and serum fibrinogen levels are the outcome.  
Various study types, as defined in Figure 1, can be considered when investigating the 
hypothesis that panleukopenia virus causes restrictive cardiomyopathy in cats.29 
Panleukopenia virus infection is the exposure, and development of restrictive cardiomyopathy 
is the outcome. In an experimental study, the exposure is manipulated: cats could be 
challenged with virus or saline control to determine the effect on development of restrictive 
cardiomyopathy. In contrast, an observational study would investigate a population of cats 
without controlling the exposure. Observational studies come in two flavors: descriptive and 
analytic. A descriptive study could report one or more cases of restrictive cardiomyopathy and 
indicate how many had evidence of panleukopenia virus infection. Or, a descriptive study could 
report on cats with natural panleukopenia virus infection, mentioning the number that had 
concurrent restrictive cardiomyopathy. In contrast, an analytic study compares two groups, 
such as reporting the frequency of panleukopenia virus infection in cats with restrictive 
cardiomyopathy and in cats without restrictive cardiomyopathy.  
Experimental studies sit proudly atop the hierarchy of evidence because exposures can be 
precisely controlled. But, let us not abandon our respect for observational studies! 
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Observational studies investigate the very animals that comprise pathologists’ routine caseload 
and are therefore highly relevant to daily practice. Observational studies are essential when 
experimental studies are impossible or undesirable. They are often easier and less expensive 
to carry out because study subjects and data may already be available or more easily 
obtained, and are well-suited to the analysis of conditions that develop over a long period of 
time. Many risk factors or outcomes can be investigated simultaneously, including interactions 
among variables. Observational studies usually contribute an early foundation of knowledge, 
before it becomes possible—if ever—to study the disease experimentally. Finally, 
observational studies are the most frequent type published within the pages of Veterinary 
Pathology (Figure 2), so it is prudent to optimize the design of these studies, as we continue to 
welcome them as a key basis for knowledge in veterinary pathology. 
Devising an observational study 
This earliest step in the study—choosing a topic—shapes its eventual impact. We suggest a 
formula for devising observational studies that will have value: 
1. Identify important problems and gaps in knowledge, and work toward solutions for them. 
2. Have an innovative mindset, being open to and actively searching for new possibilities. 
Consider observations that don’t fit with existing knowledge, and what they might mean 
for alternative understanding. Consider alternative interpretations of existing 
observations, and what might b  done to evaluate differing explanations. 
3. Use the scientific method: observations, experiences, knowledge clearly formulate a 
question or identify a problem create a hypothesis design and conduct an 
observational study critically analyze the results, their inferences and implications 
(communicate findings) refine questions/hypotheses and repeat. 
4. Apply novel methods to existing problems, if they open new areas of investigation. 
Novel methods are not enough by themselves; they must lead to new and meaningful 
knowledge. But, innovative methodologies can offer new ways of probing old problems; 
a key that opens a previously locked door. 
5. Throughout this process, recognize the essential role of creativity. A study is dull and 
meaningless without the imaginative insights and ideas that have been termed the 
creative, aha or eureka moments, the happy thought, or the art of discovery. 
6. When unexpected but seemingly valid results emerge, resist the tendency to force them 
into the mold of prior thinking. Exciting advances in knowledge are based on 
troublesome and unanticipated findings. Let the data speak. 
Most studies take unexpected twists and turns as investigators encounter and overcome 
challenges, and as surprising findings emerge. The initial plan will be modified accordingly: 
research is an iterative process that requires reflection and critical analysis at each stage of 
the study (Table 1). 
Creating the hypothesis, question or objective 
The hypothesis, question or objective is the central pillar of the study that determines the 
appropriate methodology and frames the anticipated findings (Figure 3). In crafting the 
manuscript, the Introduction, Methods, Results and Discussion are all built around the 
hypothesis or question. Studies with a strong hypothesis, question or objective are likely to 
yield specific findings of interest and can be clearly presented to readers. Studies that are 
focused on applying a new method or those in which the hypothesis, question or objective 
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were developed as the manuscript was being written often lack clear findings of value and do 
not have a strong narrative.  
The hypothesis, question or objective must be precise and specific. The aim—if the study 
proceeds according to plan—is for the results to definitively confirm or refute the hypothesis, or 
conclusively answer the question, or completely satisfy the objectives. The objectives need not 
be grandiose or world-changing but must be precisely achievable: vague or unattainable 
objectives are not of value as a solid basis for a study. Recent studies provide examples of 
effective, specific and testable hypotheses: “the histologic diagnosis of pectinate ligament 
dysplasia (PLD) [does] not correlate with the gonioscopic diagnosis of PLD, and PLD cannot 
be diagnosed solely by routine histological examination in canine globes affected with chronic 
glaucoma”,3 and “myocardial CPV-2 infection is P associated with cardiac damage in dogs 
less than 2 years old.”16  
Hypotheses must be specified before the study is conducted. If hypotheses are formed after 
observation of the data then the study is merely exploratory, and testing the hypothesis in a 
new population of study subjects would be needed to confirm the hypothesis. When 
hypotheses are formed as the paper is being written, this simply fits the “hypothesis” to the 
observed data. This is the reverse sequence—the tail now wags the dog—and thus invalidates 
the merits of hypothesis testing. 
The methodology is not part of the hypothesis, question or objective. The methodology is 
subservient and developed subsequently (Figure 3). Too often we think of cool methods and 
only later create a study objective, but this is the reverse of effective study design. 
Investigations that are not built upon on specific objectives can become an exercise in data 
collection with the hope of discovering an unexpected association. This may yield interesting 
data but is highly exploratory, and a confirmatory study would be necessary to validate such an 
association. In the same way, studies that measure a myriad of parameters generate heaps of 
information, but can become unfocused and lack statistical power to make valid inferences.  
 
Descriptive vs analytic studies 
What study design is most appropriate and practical to address the hypothesis, question or 
objective of the study? Here, we consider the gritty details of study design: descriptive vs 
analytic studies, the merits of various types of analytic studies, retrospective vs prospective 
enrollment, the number of study subjects, validation of study subjects, considerations of causal 
inferences, and the thorny topics of bias, confounding and chance associations. 
Descriptive studies are sometimes dismissed as the poor cousins of designed studies, that 
provide only weak evidence because unmeasured variables are not controlled and have an 
unknown impact on the findings. Further, cases represented in laboratory archives are a highly 
selected population that may differ in important ways from those cases of the same disease 
that were never sampled. For instance, those dogs whose tumors were biopsied and 
subsequently archived may have a substantially different clinical outcome from those dogs 
whose owners did not pursue advanced diagnostic tests. Finally, the lack of a control group 
leaves readers wondering whether the observed findings might also be seen in some normal 
animals, particularly for species or tissues not often examined. Microscopic observations in 
marine invertebrates, inclusion bodies in the ganglia of coatis, and the variety of age-related 
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lesions in older animals provide examples of “background” findings that might be incorrectly 
attributed to a disease if controls were not also examined.2,13,24,32 These issues are particularly 
pronounced for single-animal case reports, where the relationship between 2 findings might be 
explained by a host of unmeasured factors. 
Despite these limitations, descriptive studies provide undeniable value to the daily practice of 
veterinary pathology. They focus on communicating objective factual observations, relatively 
free of inference. As keepers of the archive, pathologists have unique access to a nearly 
unlimited collection of laboratory samples. For some questions, descriptive studies may be the 
best approach. For example, in a descriptive cohort study, a single defined population of 
animals initially free of the outcome is followed over time to determine the incidence of a 
disease or an outcome of the disease.38 Examples include the incidence of uterine decidual 
reaction in mice subjected to a superovulation protocol,34 and the incidence of recurrence after 
excision of feline epitheliotropic mastocytic conjunctivitis.5 Finally, the process of marshalling 
these cases for a study may identify patterns and generate hypotheses not considered during 
the routine processing of case material. Much of our knowledge in veterinary pathology is 
rooted in descriptive studies, and some of our most-downloaded and most-cited articles are 
descriptive studies of new disease conditions. Veterinary pathologists should not be apologetic 
about the position descriptive studies occupy on those evidence hierarchies that were 
designed for evaluating human medical treatments.11 
Analytic studies offer important advantages over descriptive studies because they formally 
compare results between two groups that differ with respect to the exposure or the outcome 
(Table 2). Descriptive studies have no control group, so it is impossible to determine if certain 
findings are true features of the disease or if they are alternatively due to an unrelated 
characteristic of the population or the method of acquiring the study subjects. When it is 
relevant to the study objectives, including a meaningful control group can add considerable 
value and impact to observational studies (Figure 4). If the objective of your study is to 
describe or characterize, try changing it to compare for a more powerful study design. 
An overview of the classic types of observational studies is provided in Figure 1 and detailed 
elsewhere.14,37 The merits and limitations of different analytic study designs are outlined in 
Table 3.  
Prospective vs retrospective enrollment 
Retrospective enrollment makes use of existing materials and data, which is easier, faster and 
less expensive, and generally allows increased numbers of study subjects for greater statistical 
power. Most studies published in Veterinary Pathology involve retrospective enrollment 
because veterinary pathologists have such easy access to marvelous archives of case 
material. 
Conversely, prospective enrollment allows a standardized approach to sampling and analysis, 
and the scope of data collection is intentionally designed. Thus, prospective enrollment may 
avoid bias and reduce variability by minimizing unintentional differences among samples. 
Furthermore, prospective sampling may be necessary for specialized analyses, such as flow 
cytometry or analysis of gene expression. Thus, use of prospective studies is one of the main 
recommendations for improving studies in pathology and laboratory medicine.28 But, they are 
far more costly and time-consuming, and it may be impossible to acquire a sufficient number of 
cases within a reasonable time frame. It is an unstudied marvel of biology, how even common 
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diseases seemingly disappear once a prospective study is underway. 
Study design and causal inferences 
Observational studies that focus on causality or pathogenesis require particular attention to 
study design. In experimental studies, the subjects may be more uniform and there is 
controlled manipulation of the exposure (i.e. the causative agent, or the earlier event in the 
pathogenesis). In contrast, these factors are uncontrolled in observational studies making it 
inherently difficult to show causality. When an observational study reveals an association 
between two factors, Hill’s criteria 21 (Table 4) provide a framework for considering whether the 
relationship is causal. 
The fourth of Hill’s criteria—the temporal relationship of cause and effect—can be problematic 
for studies using single biopsies or samples obtained after death. Specifically, it may be 
impossible to determine the causal sequence if the two variables are measured at a single 
point in time. For example, a landmark study46 identified the association of equine multinodular 
pulmonary fibrosis (EMPF) and equine herpesvirus 5 (EHV-5) infection. However, case-control 
or cross-sectional study designs cannot confirm the sequence of causation: does EHV-5 
infection cause EMPF, or alternatively does the abnormal tissue environment in EMPF favor 
infection with or replication of EHV-5? In this example, objective identification of the causal 
sequence was later supported by an experimental study47 (Hill’s 8th criterion in Table 4) and by 
comparative studies (Hill’s 9th criterion);45 a cohort study would be an alternative approach in 
other contexts. 
Sometimes, the direction of causality is obvious. In a cross-sectional study of zebrafish that 
identified an association between the genetic mutation ‘smoothened’ and the occurrence of 
endocardiosis, it is not plausible that endocardiosis caused the genetic mutation, but it is 
plausible that the mutation caused endocardiosis.12 Similarly, the causal sequence is self-
evident when death is the outcome, for example that canine mammary carcinosarcoma 
confers a poor survival time compared to other types of mammary carcinoma.33 In other 
studies it might be reasonable—based on existing knowledge—to infer a causal sequence, for 
example that systemic hypertension in cats with chronic renal failure led to vasa vasorum 
arteriopathy, rather than the converse.23 Nonetheless, the sequence of causality is not always 
clear in cross-sectional and case-control studies: pancreatic islets of diabetic cats more 
frequently contain T and B lymphocytes compared to pancreatic islets of control cats, but we 
can’t be sure if the lymphocytes are responding to the pathologic process in the islets, or if 
they caused the loss of islet cells.48 
Longitudinal sampling of initially outcome-free animals in a cohort study (or exposure of 
animals known to be free of the disease, in an experimental study) may be needed to show 
that exposure precedes outcome. For example, the Golden Retriever Lifetime Study follows 
dogs that are initially cancer-free over their lifetime, and is expected to identify risk factors for 
later development of 4 types of cancer.19 Studies that make use of longitudinal sampling are 
rare in Veterinary Pathology. 
Consider also if the study measures new occurrences of a disease (i.e. incident cases) or 
existing cases in a population (i.e. prevalent cases). For prevalent cases, it may be impossible 
to determine if the cause (the exposure) preceded development of disease (the outcome). 
Furthermore, since prevalence is a factor of both incidence and duration of disease, case-
control and cross-sectional study designs may not discern whether an exposure causes 
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development of new cases or increased survival of existing cases. For example, consider a 
cross-sectional study with the valid observation of a higher prevalence of amyloidosis in 
captive compared to free-ranging Island foxes.17 It is plausible that factors related to captivity 
increase the likelihood that foxes develop amyloidosis, but an alternative explanation is that 
foxes with amyloidosis survive longer in captivity than in the wild. Thus, cohort studies can be 
logistically difficult because of the need to identify animals initially free of the outcome and then 
follow them over time to determine development of the outcome. Nonetheless, cohort studies 
are considered a stronger study design than case-control and cross-sectional studies because 
they measure development of new cases rather than existing cases, and confirm that the 
proposed cause preceded development of the outcome. 
Selecting study subjects: ethics and permissions 
All research involving live animals or samples obtained for the purpose of the study require 
approval by an institutional animal care and use committee, which ensures that the study is 
conducted in accordance with relevant legislation. Permits may be required to obtain or 
possess samples obtained from threatened species or from free-ranging wildlife. Permission 
may be necessary to publish findings based on case material owned by other individuals or by 
an institution. Written informed consent is required if samples are obtained from client-owned 
animals for the purpose of the study. The situation is less consistent for studies conducted on 
archived laboratory materials sampled for the purpose of diagnosis. In many jurisdictions, 
these samples may be considered the property of the laboratory depending on agreements at 
the time of sample submission, and written informed owner consent is not required. However, 
these laws vary among jurisdictions and may change over time, and we expect this could 
become an emerging issue in the future.  
Selecting study subjects: unbiased sampling, effective controls, and inclusion and 
exclusion criteria 
When selecting animals to include in the study, choose a contiguous series of subjects in each 
study group, or a randomly selected subset. It would introduce considerable bias if we included 
only those cases that were the most interesting, had the most solid diagnosis, or were most 
memorable. This is an important critique of single-animal case reports—the reported cases are 
highly selected and thus may not be representative—but the situation is only improved in an 
analytic study if the subjects are appropriately selected. Many observational studies use all of 
the available cases, whereas our archives contain far more controls than are necessary for the 
study. How do we select which controls to include? In general, selection of a subset of study 
subjects from the larger population should be done by refining the inclusion and exclusion 
criteria or by a formal random method. Other approaches—purposive, convenience or 
haphazard sampling—are likely to bias the outcome. 
Selecting controls is key to the study design, not an afterthought. Choose controls that offer 
the best comparison to the population being studied, in the context of the study objectives. 
Often, the best controls are not normal individuals, but ones with an alternative disease. For 
example, in a study using calretinin immunohistochemistry to identify the neural tracts affected 
by equine degenerative myeloencephalopathy, 2 groups of controls were included: normal 
horses to validate the use of calretinin immunohistochemistry for tracing neural tracts, and 
horses with "other spinal disease” to show that calretinin-positive spheroids were unique to 
equine degenerative myeloencephalopathy and not found in other spinal diseases.15 Similarly, 
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in a study that determined the sensitivity and specificity of histologically visible cilia-adherent 
bacteria for diagnosis of Bordetella bronchiseptica pneumonia compared to the gold standard 
of bacterial culture, other forms of bacterial pneumonia were considered to be a more 
appropriate control instead of normal lung.41 To measure the specificity of surfactant protein A 
for diagnosis of pulmonary carcinomas, 113 non-pulmonary neoplasms were used as 
controls.4 Finally, unaffected marine invertebrates were important controls, to demonstrate that 
the histologic findings in those with either spontaneous or experimentally induced copper 
toxicosis were not simply normal findings in these little-studied species.24 Choosing the most 
appropriate controls is a fundamental basis for any analytic study and is completely dependent 
on the details of the hypothesis, question or objective of the study. 
Inclusion and exclusion criteria must be defined for both study groups; that is, for the cases as 
well as the controls. Inclusion and exclusion criteria are a precisely detailed description of how 
study subjects were selected from the population and the reasons that some subjects were 
omitted from the study. The importance of clear inclusion and exclusion criteria is not simply to 
allow replication of the experimental approach. More importantly, these criteria allow readers 
(and indeed investigators) to understand potential sources of selection bias that could 
influence the study outcomes. Effective description of inclusion and exclusion criteria read as 
poetry to discerning journal editors:  
“A search of the archives between June 2007 and November 2014 was performed [i.e. the 
method of selection of a contiguous series of cases and controls], and cases limited to cats 
at least 1 year of age were identified using the keywords feline or cat and endomyocardial 
fibrosis, endocardial fibrosis, endocardial scar, endomyocarditis, or restrictive 
cardiomyopathy [i.e. the inclusion criteria for cases]. We excluded cases having keywords 
hypertrophic and dilated [i.e. the exclusion criteria for cases]. Control cases were identified 
using keywords describing acute trauma, neoplasia, or other noncardiac causes of sudden 
death [i.e. the inclusion criteria for controls]. A similar age distribution of control cases was 
selected from the same time period and source [i.e. the method of matching controls and 
cases].”29 
After the initial round of selecting study subjects, confirm that each of them are assigned to the 
correct group. Critically evaluate that the cases are really cases and the controls are really 
controls, and they meet their respective inclusion and exclusion criteria. Validating the study 
subjects at an early stage avoids later errors introduced by reclassification and recalculation. 
False positives (erroneously diagnosed cases) are particularly problematic in case-control 
studies.  
 
Selecting study subjects: unique aspects of archived laboratory material 
Consider the target population (eg. all dogs with lymphoma), the source population from which 
samples were drawn (all dogs that have lymphoma samples in the laboratory archive) and the 
study population (the dogs entered into the study because they meet the inclusion and 
exclusion criteria), and how these populations might differ. For example, animals represented 
in laboratory archives may be more likely to have had a higher level of veterinary care, been 
treated with antibiotics, be affected by serious disease, and be affected by risk factors for other 
diseases. How will these factors affect the findings and the external validity of the study—the 
relevance of the findings to the general population of interest? 
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Both study groups should be sampled from the same population, but this is troublesome for 
laboratory-based studies where the archived material is of diverse and ill-defined provenance. 
The detailed circumstances of these animals’ life circumstances are usually unknown and not 
often considered when selecting study subjects—particularly for the controls. Thus, there is 
considerable risk that study groups will differ with respect to unmeasured variables such as 
those shown in Table 5.  
Uneven distribution of these variables between the different study groups can introduce bias or 
confounding. This problem—the possibility that clustering of unmeasured variables might 
create the false appearance of an association between the exposure and outcome being 
studied—is perhaps the major limitation of observational analytic studies based on archived 
laboratory samples. Bias and confounding are considered in more detail below. 
When working with archival samples, the process of selecting study subjects is often iterative. 
Reviewing the details of the initially selected cases and controls usually identifies problems, 
and it is typical to revise and clarify the inclusion and exclusion criteria, then restart the 
selection process. Repeating this process is tedious, but it is far better to solidify the study 
population at the beginning than to make changes after collecting the data. 
Selecting study subjects: numbers of study subjects 
It is useful to conduct a formal sample size calculation prior to carrying out the study, to 
determine the number of study subjects required to identify a significant difference between 
study groups. Online tools are available ( .g., Statulator, 
http://statulator.com/SampleSize/ss1P.html; and  StatCalc-EpiInfo, 
https://www.cdc.gov/epiinfo/index.html). If the outcome of interest is a proportion (binary 
scale), the calculation requires desired values for the level of confidence (typically 0.95) and 
statistical power (typically 0.8), as well as an estimate of the effect size. For binary variables, 
the effect size can be the odds ratio or risk ratio that the investigator considers to be 
meaningful, and this is estimated based on the anticipated proportion with the outcome in the 
exposure-positive and exposure-negative groups. If the outcome of interest is measured on a 
continuous scale, the calculation requires that investigators estimate a meaningful difference in 
the outcomes between the exposure groups, as well as the estimated variability in the 
outcome, and the desired levels for confidence and power. Thus, although the sample size 
calculation requires estimates for some variables unless a pilot study is done, it can provide an 
informative estimate of sample numbers to suggest the feasibility of finding a meaningful 
difference in the outcome between the exposure groups. 
Inadequate number of study subjects is a common limitation of studies in pathology and 
laboratory medicine28 and is a frequent critique of manuscripts submitted to Veterinary 
Pathology. Conversely, studies with large numbers of study subjects are admired by readers 
and reviewers. However, even if overall case numbers are large, the tendency for pathologists 
to be “splitters” rather than “lumpers” leads to low numbers in some categories. This was 
addressed in studies of canine pulmonary carcinoma and mammary carcinoma, by including 
sufficiently large numbers of cases—67 and 229 respectively—to permit meaningful analysis of 
tumor subtypes.4,33 
Investigators have control over the number of study subjects. Studies of archived cases could 
cover a broader time period. It may be possible to relax the inclusion criteria and limit the 
exclusion criteria, and still fulfil the study objectives. Collaboration among institutions is the 
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most effective way to increase case numbers, and brings added benefits of increasing the 
external validity, establishing professional relationships, adding expert insights, and fomenting 
discussion of the study material. For example, an investigation of oxalate nephrosis in 
cheetahs included cases from Southern Africa, North America and France, and included 
geographic origin in the statistical analysis.30 Finally, we should ensure that our laboratory 
information management systems can be effectively queried, so that a contiguous series of 
cases can be retrieved in a standardized manner. 
Refining the number of study subjects in each group can optimize statistical power. If cases 
are frequent, aim for a 1:1 ratio of cases and controls. If cases are rare enough that it will be 
difficult to achieve statistically significant results, increasing the number of controls will 
increase the statistical power of the study. However, using more than 3 or 4 controls for each 
case increases the cost of the study without much increase in statistical power. Conversely, 
having fewer controls than cases would be rarely justified. 
Bias, confounding and chance associations 
Take a deep breath, intrepid pathologist, as we plumb the final depths of epidemiology. This 
road is a hard one, but leads to a truth that we all must know. 
A statistically significant association between an exposure (e.g. presence of a virus in tissues) 
and an outcome (e.g. lesions of a particular disease) is a welcome finding in any observational 
study and cause for celebration. But, before considering that the relationship is causal—that 
the virus did indeed induce the lesion—some critical analysis is in order. Observational studies 
are susceptible to spurious associations that are not easy to detect, so investigators must 
carefully search for alternative explanations of their data.  
Consider what factors might differ between the study groups, and how these differences might 
poison the findings of the study. The study groups obviously differ in ways defined by the 
inclusion and exclusion criteria, but they might be dissimilar in other ways as listed in Table 5. 
If the frequency or distribution of 1 of these factors differs between the 2 study groups, this 
could bias the association between the exposure and the outcome. For example, this might 
give a false appearance that the exposure was associated with the outcome, or it might lessen 
or obscure a true association between exposure and outcome. 
These factors may be particularly problematic for laboratory data. In designing a clinical study 
with prospective enrollment, one would never select cases from a referral hospital and controls 
from a humane society practice, nor process and analyze case samples with one method and 
control samples with another. But these and other factors are surely variable and largely occult 
for archived laboratory case material, increasing the likelihood of spurious conclusions as a 
result of random or systematic differences between study groups. Furthermore, those 
clinicians, pathologists and laboratorians who originally managed and investigated the cases 
(and the controls) did so with full knowledge of the clinical details. Consider how this 
knowledge might have affected the case management or the laboratory investigation, and how 
these differences between study groups might affect the findings of the study. 
Finally, note the importance of the “independence of study subjects”. Using study subjects that 
are not independent of each other violates the assumptions of many statistical analyses and 
may introduce bias. For example, if an otherwise heterogeneous study population contained 
several individuals from the same herd or household, these subjects may not be independent. 
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At a broader level, clustering of data is common within animal populations because of their 
population structure, and may involve the exposure variable, the outcome variable, or both. In 
addition to affecting the statistical analysis, clustering of data may lead to bias if it affects both 
the exposure and the outcome. Furthermore, statistical methods to control for clustering may 
reduce the power of study, thus requiring larger sample sizes. 
Mitigation of bias, confounding and chance associations 
It is important to recognize potential bias and confounding factors because their effects can be 
minimized by measurement, exclusion, statistical analysis, or matching.  
1. Exclusion. Eliminate the effects of confounding by excluding a subset of the study 
subjects. In the example of selection bias from Table 6, exclude study subjects from 
primary care clinics, if they are few and if they complicate the association of nodal 
metastasis and survival. 
2. Measurement. As the study is being conducted, collect data on potential sources of 
bias and confounding, and then compare their frequency in a data table. For 
example, compare the study groups with respect to factors including those listed in 
Table 5. Is the distribution of ages the same in cases and controls? Does the 
proportion of large vs small dog breeds differ between the study groups? If so, 
consider how the differences might affect the findings of the study. As an example, 
physeal lesions were studied in bulls raised in the same geographic area with similar 
husbandry practices. The similar ages and body weights of cases and controls 
suggested that these were not confounding factors.26  
3. Analysis. Multivariable analysis or stratified analysis are frequently used to analyze 
and mitigate the effects of confounding. For example, multivariable analysis was 
used to control for the effect of age and sex in comparing the prevalence of bacterial 
infection in St Lawrence belugas in 1983–2002 vs 2003–2012,25 and would be 
effective for analysis of the sources of bias shown in Tables 5 and 6. 
4. Matching. If potentially confounding variables can be identified at the time the study 
is designed, study groups could be intentionally matched when study subjects are 
selected. For example, in a study of X-linked hereditary nephropathy in Navasota 
dogs, cases and controls were matched during the selection process with respect to 
their sex.6 Similarly, in an investigation of the relationship between squamous cell 
carcinoma and papillomavirus infection, case and control samples were matched 
with respect to sheep breed and anatomic site.44 However, factors that are matched 
cannot be analyzed as risk factors: if subjects are matched based on age, age 
cannot be analyzed as a risk factor for the outcome. Thus, multivariable statistical 
analysis may be advantageous in controlling for differences between groups while 
allowing for assessment of the factor of interest.  
Critique the study design 
Before starting data collection, it is recommended to write a study proposal and seek peer 
review. The act of writing forces appraisal of the relevant literature, planning and critical 
analysis. It tests the coherence of the various elements: the rationale, the 
hypothesis/question/objective, the study design and methodology, the expected findings, and 
the anticipated impact (Figure 3). What is our current understanding, and what is the gap in 
knowledge that the study aims to correct? What is the important problem that the study 
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addresses? Is the hypothesis, question or objective based on a clear rationale, and is it 
sufficiently specific? Are the study design and methodology expected to yield results that 
definitively test the hypothesis or answer the question? Are there conceptual flaws with respect 
to showing causality? Might unmeasured factors cause bias or confounding? Will the expected 
findings have the anticipated impact and address the problem or gap in knowledge that was 
described in the rationale? Revisit the questions posed in Table 1, as an approach to refining 
the study design and methodology. If doubt that the study results will be definitive or valuable, 
now is the time to refine the methods or revise the hypothesis, question or objective. A clear 
and detailed description of the rationale, anticipated findings, and significance of the study 
might seem as tedious work, but it allows effective critique of the study design, ensures that 
the study is solidly guided by a strong and specific hypothesis or question, and forms a guide 
for the decisions that must be made as the study is conducted (Figure 3). Moreover, writing the 
ensuing manuscript will be a breeze if this structure is in place from the beginning. 
Value-added  
Adopt a discovery mindset during the various phases of the study. The goal of an 
observational study is not usually to confirm what is known, but to discover something new. 
Critically analyze the emerging data: consider alternative interpretations, and what might be 
done to evaluate the differing possibilities. After analysis of the initial results, consider 
elements that could be added to give the study more value or impact. Discovery is iterative and 
it is a mistake to anticipate a simple progression from planning to execution to publication. 
Initial results beget additional investigations that greatly strengthen the overall work with limited 
increased effort. 
Use insights from a single case as the starting point for a more comprehensive study. A study 
of Bordetella bronchiseptica pneumonia in dogs was initiated by the microscopic observation of 
bacteria adherent to cilia, but the analytic study yielded information well beyond that of the 
index case.41 A novel herpesvirus was identified in a single bottlenose dolphin with benign 
genital plaques, which stimulated development of a case series, and eventually made use of 
banked sera from the same animals to show that seroconversion to the virus occurred at the 
age of onset of sexual behavior.43 A single case report of a pig with amyloidosis was 
transformed by bioinformatic analysis of the amyloid amino acid sequences and in vitro testing 
of amyloid fibril formation to substantially advance the understanding of pathogenesis.22 Thus, 
useful observational studies often arise from but go far beyond the observations on a single 
case. 
Finally, consider value-added outcomes that give the study a broader impact. Mechanistic 
studies may have greater application if the pathologic findings can be related to clinical 
outcomes. For example, evaluating the survival of dogs with mast cell tumor was essential to 
the impact of studies on receptor tyrosine kinase expression42 and cytologic grading.7 
Similarly, morphologic analysis of feline chronic kidney disease was given added clinical 
relevance by analyzing the relationship to measures of renal function.9 Alternatively, consider 
whether an analysis of causes or risk factors could be added to a descriptive study by 
including an appropriate comparison group. For example, a study of endocardiosis in aging 
zebrafish described the pathologic findings, but also identified associations with recirculating 
water systems, commercial diets, and a mutant smoothened gene.12 Likewise, a description of 
amyloidosis in island foxes identified increased lesion severity in older, female, and captive 
foxes as well as between subspecies.17 Creativity and a discovery mindset are the keys to 
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identifying such opportunities for added insights. Further examples include adding genetic 
analysis to a study of age-related spontaneous lesions in mice,20 comparing young and old 
animals to increase the value of a study of background lesions and clinical pathology 
parameters in laboratory beagle dogs,2 quantitative analysis to validate the concurrence of 
cardiac fibrosis and chronic renal lesions in aged chimpanzees,10 and comparing findings in 
wild and laboratory rats with respect to understanding the pathogenesis of cardiomyopathy in 
this species.36 
These ideas are summarized in Figure 5. We hope that veterinary pathologists can apply these 
principles and use imagination, insight, collaboration, and laboratory archives bursting with 
samples to transform their daily work into focused observational studies that provide value and 
impact for advancing our knowledge of animal disease.  
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Figure legends 
 
Figure 1. In an experimental study, the exposure (independent variable) is controlled and 
manipulated by the investigator. The 3 classic observational study designs differ in whether 
exposure or outcome defines how study subjects are selected. In cross-sectional studies, 
study subjects are selected without regard for either the exposure or the outcome, and the 
outcome and exposure are measured at the same time. In case-control studies, study subjects 
are selected based on the outcome, and the exposure is compared between groups with 
differing outcomes. In cohort studies, study subjects known to be free of the outcome are 
selected based on their exposure to the putative causal factor, then followed over time; 
development of the outcome is compared in study subjects with differing exposures. Examples 
of analytic studies are provided in Table 3. It is notable that comparison of diseased and 
healthy animals (often termed cases and controls by veterinary pathologists) are case-control 
studies only if subjects are selected based on their disease status and compared with respect 
to their exposure to a putative causal factor. 
 
Figure 2. Numbers of observational studies (analytic and descriptive) and experimental studies 
published in Veterinary Pathology. Most published articles are observational studies, and most 
of these are descriptive. 
 
Figure 3. Interrelationships of the various elements of study design. Studies are based on a 
clear, precisely worded, and specifically testable/answerable hypothesis, question or objective. 
The hypothesis, question or objective is supported by a clear rationale that identifies the 
problem or the gap in current knowledge. The study design and methods are developed to 
serve the hypothesis, question or objectives of the study. The methods are expected lead to an 
outcome that clearly confirms or refutes the hypothesis, answers the question, or fulfils the 
study objectives. In so doing, the anticipated results of the study fills the above-mentioned gap 
in knowledge and thus addresses the rationale of the study. 
 
Figure 4. Citations and usage of observational studies (analytic and descriptive) and 
experimental studies published in Veterinary Pathology. The data show the number of citations 
(panel A) and number of downloads (panel B) per article based on year of publication (mean 
with 95% confidence interval). Analytic studies tend to be cited and downloaded more often 
than descriptive studies (* P<0.05). Further, analytic observational studies have similar or 
higher numbers of downloads and citations as experimental studies, even though the latter is 
classically considered more a robust approach to knowledge discovery. 
 
Figure 5. Considerations for the effective design of observational studies in veterinary 
pathology. 
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Table 1. Questions to revisit at each stage of the study 
1. Will the study be a useful contribution to new knowledge, and what can be done 
now to give it additional value?  
2. What critiques will peer reviewers make, and what can be done now to mitigate 
them?  
3. Does the plan aim to conclusively address the hypothesis/ question/ objectives of 
the study, and what can be done now to ensure this occurs?  
4. Are the number of study subjects adequate, given the anticipated variability of 
the data and the magnitude of the difference between exposure groups that is 
considered to be meaningful? 
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Table 2. Some analytic observational studies in Veterinary Pathology, 2016-2017. Note 
that disease may represent either the exposure or the outcome, depending on whether 
the study investigates the causes or consequences of disease. 
Article Title Exposure Outcome 
Wooden breast 
myodegeneration of 
pectoralis major muscle over 
the growth period in broilers42 
Different age categories Morphology, severity 
and distribution of 
muscle lesions 
Changes in Foxp3-positive 
regulatory T cell number in 
the intestine of dogs with 
idiopathic inflammatory bowel 
disease and intestinal 
lymphoma29 
Inflammatory bowel disease 
vs intestinal lymphoma  
Number of Foxp3+ 
cells; level of 
interleukin-10 gene 
expression   
Prognostic significance of 
canine mammary tumor 
histologic subtypes: an 
observational cohort study of 
229 cases35 
Morphologic subtypes of 
mammary carcinoma 
Median survival time 
Cytologic criteria for mast cell 
tumor grading in dogs with 
evaluation of clinical 
outcome7 
High-grade vs low-grade 
mast cell tumor 
2-year survival 
Localization of bovine 
papillomavirus nucleic acid in 
equine sarcoids20 
Presence/absence of 
papillomavirus DNA 
Sarcoids vs various 
non-sarcoid skin 
samples 
Valvular and mural 
endocardiosis in aging 
zebrafish (Danio rerio)13 
Water systems, diet, 
genotype, presence of 
intestinal carcinoid 
Presence/absence of 
endocardiosis 
Feline panleukopenia virus is 
not associated with 
myocarditis or 
endomyocardial restrictive 
cardiomyopathy in cats31 
Presence/absence of 
parvoviral DNA 
Presence/absence of 
endomyocardial 
disease 
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Table 3. The classic analytic observational study designs.  
Design Example Potential advantages Possible limitations 
Cross-
sectional 
study 
Select 50 biopsy 
samples of canine 
liposarcoma (14 well-
differentiated, 7 myxoid, 
25 pleomorphic, 4 
dedifferentiated); 
compare high vs low 
expression of various 
growth factor receptors 
(the exposure) among 
histologic subtypes (the 
outcome).1 
Can analyze multiple 
exposures and multiple 
outcomes 
Measures prevalence of the 
exposure and of the outcome 
Practical if there is a long 
interval between exposure 
and outcome 
Consequences of the single sampling:  
• may not determine if the exposure 
preceded the outcome, which is important 
for causal inferences 
• measures prevalence (not incidence), and 
thus may not distinguish if an exposure 
affected development of the disease or 
alternatively affected the survival of 
affected animals 
Limited number of subjects in one group, if one 
of the exposures or outcomes is rare 
Case-
control 
study 
Select lung samples 
from 28 dogs with 
pulmonary fibrosis and 
18 normal controls. 
Compare the frequency 
of herpesvirus infection 
(the exposure)37 in dogs 
with and without 
Useful if the outcome is rare 
(e.g. studying causes or risk 
factors of rare diseases) 
Practical if there is a long 
interval between exposure 
and outcome 
Can analyze multiple 
exposures or putative causes 
Susceptible to bias if: 
• the method of selecting subjects for the 
different study groups affects the likelihood 
of exposure to the putative cause 
• the method for measuring the exposure 
differs between study groups 
• determination of the exposure is done with 
knowledge of the outcome or is based on 
recall 
• study groups differ in ways other than the 
outcome that defines the study 
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pulmonary fibrosis (the 
outcome). 
Measures prevalence of the 
exposure in the different 
study groups 
May not determine if the exposure preceded 
the outcome, which is important for causal 
inferences 
Cannot measure incidence or prevalence of the 
outcome 
Cohort 
study 
Select 30 dogs with the 
rare diagnosis of 
marginal zone 
lymphoma and 30 dogs 
with the frequent 
diagnosis of diffuse 
large B cell lymphoma 
(the exposure); compare 
with respect to survival 
time (the outcome).  
In a beef feedlot, select 
300 calves transported 
long distances and 300 
calves transported short 
distances (the 
exposure); compare 
with respect to the later 
Useful if the exposure is rare 
(e.g. studying consequences 
of rare diseases) 
Measures incidence (eg. 
development of new 
cases) rather than 
prevalence (eg. presence 
of existing cases) 
Establishes the temporal 
relationship of the 
exposure and the 
outcome 
Can analyze multiple 
outcomes 
Susceptible to bias if: 
• the method of selecting subjects for the 
different study groups affects the likelihood 
of developing the outcome 
• one study group is more likely to be lost to 
follow-up 
• the method for measuring the outcome 
differs between study groups 
• study groups differ in ways other than the 
exposure that defines the study 
A low dose or short duration of exposure may 
not induce the outcome 
May be difficult and expensive to enroll animals 
free of the outcome and analyze or sample 
them over time  
Cannot measure incidence or prevalence of the 
exposure 
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development of 
respiratory disease (the 
outcome). 
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Table 4. Hill’s criteria for evaluating the strength of evidence that an observed 
association is causal 23 
Criterion Explanation 
Strength of the 
association 
Animals exposed to the risk factor are more likely to develop the 
disease outcome than those not exposed, or the putative cause was 
significantly more frequent in cases vs controls. However, a 
statistically weak relationship may nonetheless be causal, as is the 
case with weak predisposing factors or genetic causes with 
incomplete penetrance. Thus, investigators should not only report the 
likelihood that the observed association is due to chance (i.e. the P 
value), but more importantly the precision of the estimate (i.e. 95% 
confidence intervals) and the strength of the association (i.e. relative 
risk or odds ratio).  
Consistency The association between exposure and outcome is consistently found 
in studies of different populations.  
Specificity Although not required, causality is supported by the observation that 
an exposure induces a specific outcome, such as a unique histologic 
lesion. 
Temporality The putative cause precedes development of the outcome; for 
example, the infection precedes disease, or development of the 
disease precedes changes in serum levels of a biomarker. Temporal 
relationships are discussed in more detail in the text. 
Biologic 
gradient or 
dose-response 
Progressively higher or more prolonged exposure to the putative 
cause is associated with a greater likelihood of disease or more 
severe disease. Such relationships need not be linear or monotonic. 
Plausibility Current understanding of pathogenesis allows for a sequence of 
events linking the causal exposure and the resulting outcome. In 
dismissing the absolute requirement for this criterion, Hill quoted 
Sherlock Holmes: “‘when you have eliminated the impossible, 
whatever remains, however improbable, must be the truth”.23 
Coherence The causal relationship “should not seriously conflict with the generally 
known facts of the natural history and biology of the disease”.23 
Although superficially similar to plausibility, coherence relates to our 
broader understanding of biology and related fields. 
Experiment Evidence supported by controlled manipulation of the independent 
variable provides strong additional support for causation. 
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Analogy There is supporting evidence that a comparable exposure causes a 
similar outcome. 
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Table 5. Factors to consider when evaluating the suitability of control or comparison 
groups. Comparison groups should be similar, except for the factor of interest. Other 
factors that differ between groups may cause bias or confounding, if their frequency or 
distribution are not similar between study groups and they are not accounted for by 
analysis.  
• Factors influencing eligibility for entry to the study 
• Demographics: age, sex, breed, body weight, geographic origin, diet 
• Animal use: types of animal production systems, use for companionship vs 
performance 
• Lifestyle: diet and nutritional status, exercise and fitness level, herd size, type of 
housing, environmental exposures 
• Health: primary vs referral clinics, quality of veterinary care, prevalence of 
infectious agents, stress, administration of antibiotics or other drugs, frequency of 
concurrent diseases, details of clinical case management, likelihood of survival 
• Details of how samples were acquired, stored, prepared, and analyzed 
• Factors that might influence subjective evaluations: blinding of the investigator, 
different operators, different day of analysis 
• Accuracy of case records or recollections of past clinical details  
• Other factors affecting the likelihood of errors in diagnosis or histologic scoring, 
erroneous measurements, or the frequency of false-negative or false-positive tests 
• Samples missing from the archive, or loss of animals to follow-up in survival 
studies. These are problematic if the lost samples differ from the included samples with 
respect to the exposure and the outcome. 
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Table 6. Reasons for spurious associations in pathology-based observational studies. 
Type of error Example 
Selection bias. 
Systematic errors in how 
animals are recruited to the 
study and assigned to the 
different study groups. 
Biopsy samples of a tumor were retrieved from a 
laboratory archive. Unexpectedly, the survival time after 
diagnosis was similar in cases with high-grade vs low-
grade tumors. However, some animals with high-grade 
tumors may have had clinical findings (e.g., ulceration of 
invasive tumors or detection of metastases) that prompted 
euthanasia without being biopsied (shown as ‘X’ in the 
graph below), whereas the clinical assessment did not 
similarly influence cases with low-grade tumors. Thus, the 
clinical findings imposed a selection bias such that only the 
least clinically aggressive high-grade tumors had biopsies 
available for study. This falsely reduced the apparent 
difference in survival between animals with high-grade and 
low-grade tumors.  
 
      
Non-differential information 
bias. 
Errors that result in incorrect 
classification of exposure or 
outcome, but have the same 
impact in both study groups 
(e.g. the same effect in cases 
and controls). 
Animals with high-grade carcinomas have shorter survival 
than those with low-grade carcinoma. However, because 
of imprecise grading criteria, or lack of suitable training or 
experience of the operator, there were errors in grading 
that increased the variability of the data. As a result, the 
study failed to identify a statistically significant difference in 
survival between groups.   
Differential information 
bias. 
Errors that result in incorrect 
classification of exposure or 
outcome, and have differing 
impacts in different study 
groups.  
In evaluating immunohistochemistry for a viral antigen, 
brown staining within foci of necrosis was more likely to be 
noticed (or more likely to be interpreted as positive), 
whereas it was more likely to be overlooked or interpreted 
as background staining within areas of normal liver. Thus, 
immunolabelling falsely appeared more frequent in cases 
with multifocal hepatic necrosis compared to normal liver. 
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• Confounding. A factor 
that is associated with the 
exposure and causally 
influences outcome, but is 
not part of the causal 
sequence linking 
exposure to outcome. A 
confounding factor is thus 
a second independent 
exposure that causes or 
causally influences the 
outcome, and is 
associated with the 
exposure being studied. 
It remains controversial whether bovine coronavirus is a 
significant cause of bronchointerstitial pneumonia. Beef 
calves tend to be infected with other viruses in addition to 
coronavirus if they have been co-mingled with calves from 
other sources, and these other viruses are known to cause 
bronchointerstitial pneumonia. Thus, other viral infections 
confound the association of bovine coronavirus and 
bronchointerstitial pneumonia. 
      
Chance. Random differences 
between study groups  
Dogs in a study of lymph node metastasis happen by 
chance to be younger than those without metastases. 
Thus, dogs with lymph node metastasis seem to have 
longer survival, but only because they happen to be 
younger than those without nodal metastasis. 
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